Literature DB >> 2340262

Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations.

S J Comiskey1, T D Heath.   

Abstract

An enzyme inhibition assay was developed to determine methotrexate-gamma-aspartate leakage from liposomes at lipid concentrations as low as 43 nM phospholipid. When negatively charged liposomes prepared with phosphatidylglycerol/cholesterol 67:33 or phosphatidylinositol/cholesterol 67:33 were incubated in 10% (v/v) newborn calf serum, they leaked over 90% of their contents in 2 min. In contrast, liposomes prepared from phosphatidylcholine/cholesterol 67:33 leaked 18% of their contents under the same conditions. The amount of negative charge required to induce liposome leakage was determined by preparing liposomes with varying amounts of phosphatidylglycerol and phosphatidylcholine. Extensive leakage was observed only from liposomes prepared with greater than 50 mol of phosphatidylglycerol per 100 mol of phospholipid. The effect of the phase transition temperature on leakage of negatively charged liposomes in 10% (v/v) serum was investigated by using a series of phosphatidylglycerols with varying acyl chain lengths. Liposomes prepared from distearoylphosphatidylglycerol or dipalmitoylphosphatidylglycerol leaked less than 18% of their contents in 10% serum, whereas liposomes prepared with dilauroylphosphatidylglycerol or unsaturated lipids leaked more than 70% of their contents. Lipoprotein removal from serum followed by treatment with lipid to remove residual apoproteins reduced the leakage from phosphatidylglycerol liposomes in 10% serum. Phosphatidylglycerol liposomes leaked 73% in the presence of human low-density lipoproteins, but only 29% in the presence of bovine apolipoprotein A-I, and 25% in the presence of human high-density lipoproteins. Phosphatidylglycerol/cholesterol and phosphatidylserine/cholesterol liposomes leaked 67% in 4 mg/mL bovine serum albumin purified by cold ethanol extraction. The leakage of liposomes in albumin solutions could be substantially reduced by treating the albumin with lipid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340262     DOI: 10.1021/bi00467a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs.

Authors:  K Amin; K Y Ng; C S Brown; M S Bruno; T D Heath
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

2.  Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice.

Authors:  Aaron Peng; Robert M Straubinger; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2010-06-02       Impact factor: 4.009

Review 3.  Polymer-Modified Liposomes for Drug Delivery: From Fundamentals to Applications.

Authors:  Yifeng Cao; Xinyan Dong; Xuepeng Chen
Journal:  Pharmaceutics       Date:  2022-04-02       Impact factor: 6.525

Review 4.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 5.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Liposomes for use in gene delivery.

Authors:  Daniel A Balazs; Wt Godbey
Journal:  J Drug Deliv       Date:  2010-12-15

7.  Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation.

Authors:  Heba A Abou-Taleb; Rasha A Khallaf; Jelan A Abdel-Aleem
Journal:  Drug Des Devel Ther       Date:  2018-10-17       Impact factor: 4.162

8.  Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.

Authors:  Wenli Zhang; Caibin Li; Ya Jin; Xinyue Liu; Zhiyu Wang; John P Shaw; Bruce C Baguley; Zimei Wu; Jianping Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 9.  The Yin and Yang of the protein corona on the delivery journey of nanoparticles.

Authors:  Yi-Feng Wang; Yaxin Zhou; JiaBei Sun; Xiaotong Wang; Yaru Jia; Kun Ge; Yan Yan; Kenneth A Dawson; Shutao Guo; Jinchao Zhang; Xing-Jie Liang
Journal:  Nano Res       Date:  2022-09-16       Impact factor: 10.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.